XML 80 R62.htm IDEA: XBRL DOCUMENT v3.24.1
Revenue - Summary of Sales by Product Categories (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]    
Total $ 113,450 $ 102,290
Sales of Pharmaceutical Products    
Disaggregation of Revenue [Line Items]    
Total $ 113,450 100,876
License of Intellectual Property    
Disaggregation of Revenue [Line Items]    
Total   $ 1,414